Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis-Reference-Cited by-同舟云学术

Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis

Published:2010-11-28 Issue:1 Volume:7 Page:41-50
ISSN:1552-4450
Container-title:Nature Chemical Biology
language:en
Short-container-title:Nat Chem Biol

Author:

Di Paolo Julie A,Huang Tao,Balazs Mercedesz,Barbosa James,Barck Kai H,Bravo Brandon J,Carano Richard A D,Darrow James,Davies Douglas R,DeForge Laura E,Diehl Lauri,Ferrando Ronald,Gallion Steven L,Giannetti Anthony M,Gribling Peter,Hurez Vincent,Hymowitz Sarah G,Jones Randall,Kropf Jeffrey E,Lee Wyne P,Maciejewski Patricia M,Mitchell Scott A,Rong Hong,Staker Bart L,Whitney J Andrew,Yeh Sherry,Young Wendy B,Yu Christine,Zhang Juan,Reif Karin,Currie Kevin S

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/nchembio.481.pdf

Reference50 articles.

1. Vincent, C., Nogueira, L., Clavel, C., Sebbag, M. & Serre, G. Autoantibodies to citrullinated proteins: ACPA. Autoimmunity 38, 17–24 (2005).

2. Nell, V.P. et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann. Rheum. Dis. 64, 1731–1736 (2005).

3. Cook, A.D., Rowley, M.J., Mackay, I.R., Gough, A. & Emery, P. Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum. 39, 1720–1727 (1996).

4. Panayi, G.S. B cell-directed therapy in rheumatoid arthritis–clinical experience. J. Rheumatol. Suppl. 73, 19–24 discussion 29–30 (2005).

5. Nimmerjahn, F. & Ravetch, J.V. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34–47 (2008).

Cited by 289 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bruton’s tyrosine kinase: A promising target for treating systemic lupus erythematosus;International Immunopharmacology;2024-12

2. Comprehensive Characterization of BTK Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Non-covalent Mechanistic Signatures;2024-09-08

3. Therapeutic potential and recent progression of BTK inhibitors against rheumatoid arthritis;Chemical Biology & Drug Design;2024-07

4. Covalent Targeting Drug Mediated Specific Lanthanide Tagging Towards In Situ Bruton's Tyrosine Kinase Quantification Using ICP-MS;Atomic Spectroscopy;2024-05-14

5. Effects of Quinidine or Rifampin Co‐administration on the Single‐Dose Pharmacokinetics and Safety of Rilzabrutinib (PRN1008) in Healthy Participants;Clinical Pharmacology in Drug Development;2024-04-16